Bausch+Lomb UK eye drop recall

Article

Minims Eye Drops Solution has been recalled in the UK only, reveals the latest statement from Bausch+Lomb.

Minims Eye Drops Solution has been recalled in the UK only, reveals the latest statement from Bausch+Lomb.

The recall on over 36,000 bottles of proxymetacaine 0.5% refers to batch #F50052 with an expiry date July 2014. It was initiated on 10 December 2012 and does not include the USA or Asia Pacific region.

Although there have been no reports of adverse events caused by the eye drops, Bausch+Lomb advise customers not to use them for safety reasons.

Alison Bunce, pharmaceutical assessor, Defective Medicines Report Centre, commented, "We chose to initiate this recall after confirming a report of the presence of foreign particles in product from this single lot. No adverse events have been reported which have been attributed to the defective product in this single lot. No other lots have been affected. No other products in the Minims range or other B+L products are affected by this action. We are working closely with the MHRA to provide updated information regarding this recall action."

For further details please call +44 208 781 2991

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.